NasdaqGS - Delayed Quote USD

GeneDx Holdings Corp. (WGSWW)

Compare
0.2225
-0.0170
(-7.10%)
At close: January 10 at 4:00:00 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Ms. Katherine A. Stueland President, CEO & Director 745.91k -- 1976
Mr. Kevin Feeley CPA Chief Financial Officer 488.19k -- 1981
Dr. Bryan M. Dechairo Ph.D. Chief Operating Officer -- -- 1974
Mr. Eric Olivares Ph.D. Chief Product & Technology Officer -- -- --
Ms. Heidi C. Chen J.D. Chief Legal Officer -- -- 1967
Ms. Jami Biliboaca Head of People Strategy -- -- --
Mr. Paul Kruszka FACMG, M.D., M.P.H. Chief Medical Officer -- -- --
Ms. Melanie Duquette Chief Growth Officer -- -- --
Ms. Karen Ponchner Head of Operations -- -- --
Sabrina Dunbar Chief of Staff -- -- --

GeneDx Holdings Corp.

North Tower
6th Floor 333 Ludlow Street
Stamford, CT 06902
United States
888 729 1206 https://www.genedx.com
Sector: 
Healthcare
Full Time Employees: 
1,000

Description

GeneDx Holdings Corp., a genomics company, provides personalized and actionable health insights to inform diagnosis, direct treatment, and improve drug discovery. The company accelerate the use of genomics and leverage clinical data to enable precision medicine as the standard of care. It utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process DNA-containing samples, analyzes information about patient-specific genetic variation, and generates test reports for clinicians and their patients. The company offers genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

Corporate Governance

GeneDx Holdings Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers